BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37864903)

  • 21. Maternal exposure to perfluoroalkyl chemicals and anogenital distance in the offspring: A Faroese cohort study.
    Christensen JVR; Bangash KK; Weihe P; Grandjean P; Nielsen F; Jensen TK; Petersen MS
    Reprod Toxicol; 2021 Sep; 104():52-57. PubMed ID: 34182087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal exposure to perfluorodecanoic acid is associated with lower circulating concentration of adrenal steroid metabolites during mini puberty in human female infants. The Odense Child Cohort.
    Jensen RC; Glintborg D; Gade Timmermann CA; Nielsen F; Kyhl HB; Frederiksen H; Andersson AM; Juul A; Sidelmann JJ; Andersen HR; Grandjean P; Andersen MS; Jensen TK
    Environ Res; 2020 Mar; 182():109101. PubMed ID: 32069767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: A multi-cohort study.
    Beglarian E; Costello E; Walker DI; Wang H; Alderete TL; Chen Z; Valvi D; Baumert BO; Rock S; Rubbo B; Aung MT; Gilliland FD; Goran MI; Jones DP; McConnell R; Eckel SP; Conti DV; Goodrich JA; Chatzi L
    Environ Res; 2024 Mar; 244():117611. PubMed ID: 38061983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mass density following developmental exposures to perfluoroalkyl substances (PFAS): a longitudinal cohort study.
    Blomberg A; Mortensen J; Weihe P; Grandjean P
    Environ Health; 2022 Nov; 21(1):113. PubMed ID: 36402982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between early-childhood exposure to perfluoroalkyl substances and ADHD symptoms: A prospective cohort study.
    Kim JI; Kim BN; Lee YA; Shin CH; Hong YC; Døssing LD; Hildebrandt G; Lim YH
    Sci Total Environ; 2023 Jun; 879():163081. PubMed ID: 36972880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.
    Oulhote Y; Steuerwald U; Debes F; Weihe P; Grandjean P
    Environ Int; 2016 Dec; 97():237-245. PubMed ID: 27692925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal Exposures to Perfluoroalkyl Acids and Associations with Markers of Adiposity and Plasma Lipids in Infancy: An Odense Child Cohort Study.
    Jensen RC; Andersen MS; Larsen PV; Glintborg D; Dalgård C; Timmermann CAG; Nielsen F; Sandberg MB; Andersen HR; Christesen HT; Grandjean P; Jensen TK
    Environ Health Perspect; 2020 Jul; 128(7):77001. PubMed ID: 32628516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
    Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
    Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
    Guo M; Yu Y; Liu H; Zhu C
    Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
    Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
    Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure to perfluoroalkyl substances and neurodevelopment in 2-year-old children: A prospective cohort study.
    Luo F; Chen Q; Yu G; Huo X; Wang H; Nian M; Tian Y; Xu J; Zhang J; Zhang J;
    Environ Int; 2022 Aug; 166():107384. PubMed ID: 35834943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to Perfluoroalkyl Substances during Fetal Life and Pubertal Development in Boys and Girls from the Danish National Birth Cohort.
    Ernst A; Brix N; Lauridsen LLB; Olsen J; Parner ET; Liew Z; Olsen LH; Ramlau-Hansen CH
    Environ Health Perspect; 2019 Jan; 127(1):17004. PubMed ID: 30628845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.